Cognition Therapeutics shares owned by Smith Anglin Financial
Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Smith Anglin Financial
from 13F filings
Historical chart of Smith Anglin Financial investment in Cognition Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cognition Therapeutics held by Smith Anglin Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cognition Therapeutics by Smith Anglin Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $3.7k | 12k | 0.31 |
| 2025-03-31 | $5.0k | 12k | 0.42 |
| 2024-12-31 | $8.4k | 12k | 0.70 |
| 2024-09-30 | $5.6k | 12k | 0.47 |
| 2024-06-30 | $20k | 12k | 1.66 |
| 2024-03-31 | $22k | 12k | 1.82 |
| 2023-12-31 | $22k | 12k | 1.85 |